-
Company Profile
Max Healthcare Institute Ltd – Company Profile
Max Healthcare Institute Ltd (Max Healthcare Institute), a subsidiary of Max India Ltd, is a healthcare service provider that operates a chain of hospitals. The hospital offers urology, oncology, orthopedics, eye care, dermatology, lung transplant, nutrition, dental care, gastroenterology and rehabilitation services. It also offers services such as heart, cancer treatment, children care, diabetes, emergency and trauma, family medicine, hearing, home care, hospice, neurology, occupational medicine, orthopedics, palliative care, psychiatry, radiology, rehabilitation and therapy services and enabling patients to improve...
Add to Basket -
Product Insights
Cardiac Rhythm Management Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Cardiac Rhythm Management Devices Pipeline Market Report Overview Cardiac Rhythm Management (CRM) devices are those devices which are used to restore the natural synchronized pumping rhythm of the heart. These include Pacemakers, Cardiac Resynchronisation Therapy (CRT), Implantable Loop Recorders and Implantable Cardioverter Defibrillators (ICD). These devices are used for the treatment of congestive heart failure. The Cardiac Rhythm Management Devices pipeline market research report provides comprehensive information about the Cardiac Rhythm Management Devices pipeline products with comparative analysis of the...
-
Product Insights
Coronary Stents Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Coronary Stents Pipeline Market Report Overview A stent is an expandable perforated tube that is inserted into a natural conduit of the body to prevent or counteract a disease-induced localized flow constriction. The main goal of the stent is to hold the inner wall in its compressed position and retain the enlarged vessel diameter. Coronary stents are used in the coronary vasculature and include bioabsorbable stents (BAS), drug eluting stents (DES), bare metal stents (BMS) and covered stents. Coronary stent...
-
Product Insights
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Myeloma Pipeline Products Market Report Overview Multiple myeloma is a type of cancer that is caused by malignant plasma cells that proliferate in the bone marrow and produce abnormally high amounts of a special protein. The exact cause of multiple myeloma is not clear. It mainly affects older adults. Symptoms include anemia, bleeding, nerve damage, skin lesions, bone tenderness or pain, and kidney failure. Treatment includes chemotherapy, radiation, immunosuppression, and surgery. The Multiple Myeloma Drugs in Development market research...
-
Sector Analysis
Orthobiologics Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2022 Update
Orthobiologics are biomaterials used in orthopedic surgery as an adjunct to faster fusion and healing of the bone. The orthobiologics category covers bone graft substitutes, bone growth stimulators, cartilage repair and viscosupplementation products. The orthobiologics pipeline market research report provides comprehensive information about the orthobiologics pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
-
Product Insights
Idiopathic Pulmonary Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Idiopathic Pulmonary Fibrosis (IPF) symptoms include dry cough, shortness of breath, especially during or after physical activity, lasting tiredness, and weight loss. Treatment includes antioxidants, biological response modulators, anti-fibrotic agents, and anticoagulants. The IPF pipeline drugs market research report provides an analysis of the IPF drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the descriptive pharmacological action of the therapeutics, its complete research and development history...
-
Product Insights
Kidney Fibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Fibrosis – Drugs In Development, 2022, provides an overview of the Kidney Fibrosis (Genito Urinary System And Sex Hormones) pipeline landscape. Accumulation of extracellular matrix in the kidney causes kidney fibrosis. It is a progressive disorder characterized by glomerulosclerosis and tubulointerstitial fibrosis and may lead to detrimental effects on the kidney functioning. Predisposing factors are trauma, injury, infections, surgery, environmental factors and exposure to chemicals or radiation. Symptoms include...
-
Product Insights
Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pancreatic Cancer – Drugs In Development, 2022, provides an overview of the Pancreatic Cancer (Oncology) pipeline landscape. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas. This is also called exocrine cancer. Signs and symptoms include upper abdominal pain that may radiate to back, yellowing of skin and the whites of eyes (jaundice), loss of appetite, weight loss, depression and blood...
-
Product Insights
Non-Alcoholic Steatohepatitis (NASH) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Non-alcoholic steatohepatitis (NASH) is liver inflammation caused by a buildup of fat in the liver. NASH can get worse and cause scarring of the liver, which leads to cirrhosis. Symptoms of NASH include fatigue, weight loss for no clear reason, general weakness and an ache in the upper right part of belly. Risk factors include obesity, type 2 diabetes, high cholesterol and high triglycerides and metabolic syndrome. The NASH drugs in development market research report provides comprehensive information on the...
-
Product Insights
Syringes, Needles and Urinary Catheters Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
A syringe is a tube-like device used to intake and expel liquid. A needle is a very thin piece of tubular metal with a hollow interior. Needles are generally fitted with a plastic connector. A urinary catheter is a thin piece of flexible tubing that is used to collect urine from a patient into a drainage bag. GlobalData's Medical Devices sector report, “Syringes, Needles and Urinary Catheters - Medical Devices Pipeline Product Landscape, 2021" provides comprehensive information about the Syringes,...